Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02788617 · ClinicalTrials.gov registry record
Evaluation of the Efficacy of Diafert in Predicting Embryos' Potential to Develop to the Blastocyst Stage
A clinical trial, sponsored by Forest Laboratories.
- Completed
- Registry status
- 100
- Enrollment target
NCT02788617 is a clinical trial that has completed, run by Forest Laboratories. The registered enrollment target is 100 participants.
The verdict
NCT02788617 has completed, sponsored by Forest Laboratories.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
This prospective study will evaluate the efficacy of Diafert as an adjunct to morphological assessment in predicting embryos' potential to develop to the blastocyst stage on Day 5.
Interventions
- DEVICE Diafert
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2016-06-24 |
| Est. Completion | 2017-04-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02788617
The ClinicalTrials.gov registry entry for NCT02788617 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Forest Laboratories, which has 145 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Diafert is the first listed.
NCT02788617 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02788617 about?
NCT02788617 is a clinical study titled "Evaluation of the Efficacy of Diafert in Predicting Embryos' Potential to Develop to the Blastocyst Stage". This prospective study will evaluate the efficacy of Diafert as an adjunct to morphological assessment in predicting embryos' potential to develop to the blastocyst stage on Day 5.
What is the current status of trial NCT02788617?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2016-06-24. Estimated completion is 2017-04-04.
What interventions are being tested in trial NCT02788617?
The interventions under investigation include: Diafert (DEVICE).
Who is sponsoring clinical trial NCT02788617?
This trial is sponsored by Forest Laboratories, which has 145 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.